Intercept Pharmaceuticals | ICPT - Modal Pinjaman



Modal Pinjaman Perubahan Tanggal
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Enanta Pharmaceuticals USD 0 0 2024-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Galectin Therapeutics USD 93.42M 9.08M 2024-06
Gilead Sciences USD 22.13B 6M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Incyte USD 30.2M 5.17M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Moderna USD 610M 584M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03